ALS-FTD Clinicopathological Overlap

Thursday, August 20 at 10 a.m. CT

ALS and frontotemporal dementia (FTD) are increasingly understood to share underlying biological connections, and some people living with ALS may also experience changes in thinking, behavior, or personality.  Join Dr. David Irwin from Penn Medicine, as he explores the relationship between ALS and ALS-FTD, explaining what current research tells us about how these conditions overlap.  This session will help you understand what cognitive and behavioral changes to watch for, how they may show up over the course of the disease, and what this means for care and support planning.  

The Les Turner ALS Foundation is proud to offer this webinar at no cost to the ALS community. Thank you to the Gilbert & Jacqueline Fern Foundation, Biogen & Shionogi for sponsoring this webinar. 

About the Speaker: David Irwin, MD 

Dr. David Irwin is the clinical director of the Penn Frontotemporal Degeneration Center and PI of the Penn Digital Neuropathology Lab at the University of Pennsylvania Perelman School of medicine. He has dual training in cognitive neurology and neuropathology, and his lab focuses on integrating human brain histopathology and molecular techniques with antemortem clinical data, with the overall goal of identifying therapeutic targets and markers of disease progression that can serve as endpoints in treatment trials for FTD, ALS, LBD, AD and related neurodegenerative disorders.